Similar articles

• Bradykinin B1 receptor antagonists as potential therapeutic agents for pain.

  Huang H, Player MR. Huang H, et al. J Med Chem. 2010 Aug 12;53(15):5383-99. doi: 10.1021/jm1000776. J Med Chem. 2010. PMID: 20369879 No abstract available.
• Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.

  Biswas K, Li A, Chen JJ, D'Amico DC, Fotsch C, Han N, Human J, Liu Q, Norman MH, Riahi B, Yuan C, Suzuki H, Mareska DA, Zhan J, Clarke DE, Toro A, Groneberg RD, Burgess LE, Lester-Zeiner D, Biddlecome G, Manning BH, Arik L, Dong H, Huang M, Kamassah A, Loeloff R, Sun H, Hsieh FY, Kumar G, Ng GY, Hungate RW, Askew BC, Johnson E. Biswas K, et al. J Med Chem. 2007 May 3;50(9):2200-12. doi: 10.1021/jm070055c. Epub 2007 Apr 5. J Med Chem. 2007. PMID: 17408249
• 2,3-diaminopyridine bradykinin B1 receptor antagonists.

  Kuduk SD, Ng C, Feng DM, Wai JM, Chang RS, Harrell CM, Murphy KL, Ransom RW, Reiss D, Ivarsson M, Mason G, Boyce S, Tang C, Prueksaritanont T, Freidinger RM, Pettibone DJ, Bock MG. Kuduk SD, et al. J Med Chem. 2004 Dec 16;47(26):6439-42. doi: 10.1021/jm049394l. J Med Chem. 2004. PMID: 15588075
• Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain.

  Campos MM, Leal PC, Yunes RA, Calixto JB. Campos MM, et al. Trends Pharmacol Sci. 2006 Dec;27(12):646-51. doi: 10.1016/j.tips.2006.10.007. Epub 2006 Oct 20. Trends Pharmacol Sci. 2006. PMID: 17056130 Review.
• Bradykinin B1 receptor antagonists: a patent update 2009 - 2012.

  Bozó É, Éles J, Keserű GM. Bozó É, et al. Expert Opin Ther Pat. 2012 Dec;22(12):1443-52. doi: 10.1517/13543776.2012.730521. Epub 2012 Oct 3. Expert Opin Ther Pat. 2012. PMID: 23033970 Review.